MedicaidCoverageMedium impact
No HFS Coverage for Off-Label Utilization of Ivermectin for Prevention or Treatment of COVID-19
Illinois Medicaid - HFS·IL · Family Medicine, Internal Medicine, General Practice +2 more·Provider Notice
Effective date
Sep 29, 2021
We identified it
Jun 20, 2026
Summary
Illinois Medicaid will not cover Ivermectin for COVID-19 prevention or treatment through any program including fee-for-service and HealthChoice Illinois managed care plans. Prior authorization requests for COVID-19 related Ivermectin use will be denied, though coverage continues for FDA-approved parasitic infections.
Action Required
Immediately: Billing team must stop submitting Ivermectin claims for COVID-19 prevention or treatment to Illinois Medicaid programs. Update prior authorization systems to reflect automatic denials for COVID-19 indications. Continue normal billing processes for FDA-approved indications like strongyloidiasis and onchocerciasis with required prior authorization.